Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
Sectra AB
STO:SECT B
|
SE |
|
E
|
Euro Cervantes SOCIMI SA
MAD:YEUR
|
ES |
|
G
|
GBLT Corp
XTSX:GBLT
|
CA |
|
M
|
Marel hf
ICEX:MAREL
|
IS |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
Wall Street
Price Targets
INKT Price Targets Summary
Mink Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
INKT
is 39.78 USD
with a low forecast of 35.35 USD and a high forecast of 45.15 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is INKT's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for
INKT
is 39.78 USD
with a low forecast of 35.35 USD and a high forecast of 45.15 USD.